RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
304,244,163
Share change
-1,095,976
Total reported value
$1,609,644,830
Put/Call ratio
96%
Price per share
$5.29
Number of holders
330
Value change
-$29,277,099
Number of buys
199
Number of sells
106

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q1 2025

As of 31 Mar 2025, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 330 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 304,244,163 shares. The largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock, Inc., SOFTBANK GROUP CORP., Kinnevik AB (publ), STATE STREET CORP, Mubadala Investment Co PJSC, Novo Holdings A/S, and MIC Capital Management UK LLP. This page lists 332 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.